The Baltimore-based company is voluntarily recalling the antibiotic for being subpotent, according to the report.
The drug is manufactured by Novel Laboratories for Lupin.
More articles on pharmacy:
Hospital-owned drug company attracts 12 more health systems
How nurses are becoming integral to pharma marketing: 7 notes
4 tips for managing drug spend from Alameda Health System’s Dr. Yi-Chih Peng
Register to Attend Webinar
Presenters:
Frank Stevens, Strata|Josh Wiggins, Strata
Next Up in Pharmacy
-
New customs requirements taking effect Oct. 22 could disrupt access for millions of Americans who buy prescription drugs from Canadian…
-
The American Hospital Association is urging Congress to permanently bar rebate models in the 340B program. AHA issued the request…
-
Eli Lilly received FDA approval Sept. 24 for Onswik, a once-weekly basal insulin injection for adults with Type 2 diabetes.…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
